MEK Inhibitors

CIP-137401 Lead MEK Inhibitor

Ut molestie a, ultricies porta urna. Vestibulum commodo volutpat a, convallis ac, laoreet enim. Phasellus fermentum in, dolor. Pellentesque facilisis. Nulla imperdiet sit amet magna. Vestibulum dapibus, mauris nec malesuada fames ac turpis velit, rhoncus eu, luctus et interdum adipiscing wisi. Aliquam erat ac ipsum. Integer aliquam purus. Quisque lorem tortor fringilla sed, vestibulum id.

Novel MEK inhibitor with best in class potential

Superior pharmacokinetic profile

Novel intellectual property

Design of a new class of MEK inhibitor

AlloMek's novel class of MEK inhibitors were designed based on x-ray crystal structure information to improve potential liabilities of MEK compounds currently in the clinic

Allosteric Inhibition

Allosteric kinase inhibitors have a unique way of binding to the enzyme. Allosteric kinase inhibitors bind to the enzyme in a site distinct from the "active site". Allosteric kinase inhibitors are not ATP competitive and this leads to a higher level of selectivity vs. other kinases. Allosteric MEK inhibitors have been tested against over 200 kinases and are not active.

You are in a good hands....